We are live on ! Find out more
LG

LaFleur & Godfrey Portfolio holdings

AUM $842M
1-Year Est. Return 24.12%
This Fund
S&P 500
This Quarter Est. Return
-5.69%
1 Year Est. Return
+24.12%
3 Year Est. Return
+85.19%
5 Year Est. Return
+109.34%
10 Year Est. Return
+386.09%
AUM
$335M
AUM Growth
-$26.9M
Cap. Flow
-$799K
Cap. Flow %
-0.24%
Top 10 Hldgs %
45.78%
Holding
84
New
7
Increased
31
Reduced
28
Closed
7

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$8.21M
2
MRK icon
Merck
MRK
+$6.27M
3
IDXX icon
Idexx Laboratories
IDXX
+$5.45M
4
AAPL icon
Apple
AAPL
+$3.59M
5
RPM icon
RPM International
RPM
+$2.58M

Top Sells

Rank Stock Value
1
CVX icon
Chevron
CVX
+$7.5M
2
COP icon
ConocoPhillips
COP
+$6.64M
3
BLK icon
Blackrock
BLK
+$4.6M
4
PRGO icon
Perrigo
PRGO
+$4.2M
5
VMI icon
Valmont Industries
VMI
+$2.61M

Sector Composition

Rank Sector Weight
1 Healthcare 24.2%
2 Technology 18.22%
3 Industrials 16.87%
4 Financials 13.04%
5 Miscellaneous 9.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.67T
$30.4M 9.08%
1,101,700
+122,488
+13% +$3.59M
ECL icon
2
Ecolab
ECL
$80.4B
$16.5M 4.92%
150,136
+340
+0.2% +$38K
RTN
3
DELISTED
Raytheon Company
RTN
$15.6M 4.67%
143,131
+7,215
+5% +$754K
USB icon
4
US Bancorp
USB
$97.3B
$14.8M 4.43%
361,534
+1,515
+0.4% +$65.6K
WFC icon
5
Wells Fargo
WFC
$262B
$14.6M 4.37%
284,935
+420
+0.1% +$23.1K
INTC icon
6
Intel
INTC
$473B
$14.4M 4.32%
479,365
+45,601
+11% +$1.32M
SRCL
7
DELISTED
Stericycle Inc
SRCL
$13.5M 4.03%
96,848
-13,720
-12% -$1.91M
VAR
8
DELISTED
Varian Medical Systems, Inc.
VAR
$12M 3.59%
185,570
+4,898
+3% +$357K
ABBV icon
9
AbbVie
ABBV
$451B
$11.9M 3.54%
217,919
+21,390
+11% +$1.39M
PAYX icon
10
Paychex
PAYX
$45.2B
$9.44M 2.82%
198,238
+7,690
+4% +$359K
JPM icon
11
JPMorgan Chase
JPM
$951B
$9.29M 2.78%
152,316
+125,290
+464% +$8.21M
SYK icon
12
Stryker
SYK
$127B
$8.41M 2.51%
89,403
+6,335
+8% +$628K
JNJ icon
13
Johnson & Johnson
JNJ
$646B
$6.72M 2.01%
72,021
+1,776
+3% +$172K
DHR icon
14
Danaher
DHR
$152B
$6.26M 1.87%
109,259
+1,094
+1% +$64.6K
GNTX icon
15
Gentex
GNTX
$4.78B
$6.04M 1.8%
389,346
-10,126
-3% -$161K
LKQ icon
16
LKQ Corp
LKQ
$6.46B
$5.91M 1.77%
208,395
-900
-0.4% -$27.4K
IDXX icon
17
Idexx Laboratories
IDXX
$43.7B
$5.65M 1.69%
+76,095
New +$5.45M
CHD icon
18
Church & Dwight Co
CHD
$24B
$5.58M 1.67%
133,000
-2,480
-2% -$106K
MRK icon
19
Merck
MRK
$366B
$5.56M 1.66%
+118,036
New +$6.27M
HOLX
20
DELISTED
Hologic
HOLX
$5.55M 1.66%
141,812
-14,930
-10% -$592K
CPRT icon
21
Copart
CPRT
$30.5B
$5.45M 1.63%
1,325,984
-9,000
-0.7% -$39.8K
PRGO icon
22
Perrigo
PRGO
$2.01B
$5.3M 1.58%
33,696
-22,892
-40% -$4.2M
IGSB icon
23
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$5.11M 1.53%
97,294
-2,560
-3% -$135K
PEP icon
24
PepsiCo
PEP
$193B
$5.07M 1.52%
53,785
-563
-1% -$53.6K
ARMH
25
DELISTED
ARM HOLDINGS PLC ADS
ARMH
$4.95M 1.48%
114,484
+9,060
+9% +$404K

Similar funds

LaFleur & Godfrey's Q3 2015 Portfolio in Review

As of Q3 2015, LaFleur & Godfrey held 84 positions worth $335M, down 7.4% from $361M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

LaFleur & Godfrey's Q3 2015 filing shows 7 new, 31 increased, 28 reduced and 7 closed positions. Its largest new stake was Merck: 118,036 shares worth $5.56M. The largest sale was Chevron, an estimated $7.5M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, up from 22% a quarter earlier, followed by Technology and Industrials.

  • LaFleur & Godfrey's largest Q3 2015 buy was Merck: 118,036 shares worth $5.56M.
  • LaFleur & Godfrey added most to JPMorgan Chase in Q3 2015, an estimated $8.21M increase.
  • LaFleur & Godfrey's biggest Q3 2015 reduction was Chevron, cutting an estimated $7.5M.
  • LaFleur & Godfrey fully exited Valmont Industries in Q3 2015, selling an estimated $2.61M.
  • LaFleur & Godfrey's ten largest holdings make up 46% of its $335M portfolio in Q3 2015.
  • LaFleur & Godfrey opened 7 new positions and closed 7 in Q3 2015.
  • LaFleur & Godfrey's portfolio value fell 7.4% quarter-over-quarter to $335M.

Based on LaFleur & Godfrey's 13F filing for Q3 2015, filed 23 Oct 2015.